P08684 |
CP3A4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08684 |
CP3A4_HUMAN |
Atopic eczema [ICD-11: EA80] |
P08684 |
CP3A4_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
P08183 |
MDR1_HUMAN |
Lung cancer [ICD-11: 2C25] |
P08183 |
MDR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08183 |
MDR1_HUMAN |
Bacterial infection [ICD-11: 1A00-1C4Z] |
P08183 |
MDR1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P08183 |
MDR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P08183 |
MDR1_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P14679 |
TYRO_HUMAN |
Acquired hypermelanosis [ICD-11: ED60] |
P14679 |
TYRO_HUMAN |
Acquired hypomelanotic disorder [ICD-11: ED63] |
P14679 |
TYRO_HUMAN |
Melanoma [ICD-11: 2C30] |
P14679 |
TYRO_HUMAN |
Acquired melanotic macule/lentigine [ICD-11: ED61] |
P14679 |
TYRO_HUMAN |
Mineral absorption/transport disorder [ICD-11: 5C64] |
P14679 |
TYRO_HUMAN |
Skin pigmentation genetic disorder [ICD-11: EC23] |
P14679 |
TYRO_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P08908 |
5HT1A_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
P08908 |
5HT1A_HUMAN |
Depression [ICD-11: 6A70-6A7Z] |
P08908 |
5HT1A_HUMAN |
Hypertension [ICD-11: BA00-BA04] |
P08908 |
5HT1A_HUMAN |
Migraine [ICD-11: 8A80] |
P08908 |
5HT1A_HUMAN |
Mood disorder [ICD-11: 6A60-6E23] |
P08908 |
5HT1A_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P08908 |
5HT1A_HUMAN |
Sexual dysfunction [ICD-11: HA00-HA01] |
P08908 |
5HT1A_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P08908 |
5HT1A_HUMAN |
Attention deficit hyperactivity disorder [ICD-11: 6A05] |
P08908 |
5HT1A_HUMAN |
Juvenile idiopathic arthritis [ICD-11: FA24] |
P08908 |
5HT1A_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P08908 |
5HT1A_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P08908 |
5HT1A_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P08908 |
5HT1A_HUMAN |
Psoriasis [ICD-11: EA90] |
P08908 |
5HT1A_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P08908 |
5HT1A_HUMAN |
Skin/mucosal anomaly [ICD-11: LD27] |
P08908 |
5HT1A_HUMAN |
Tonus and reflex abnormality [ICD-11: MB47] |
P08908 |
5HT1A_HUMAN |
Intellectual development disorder [ICD-11: LD90] |
P08908 |
5HT1A_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P08908 |
5HT1A_HUMAN |
Bipolar disorder [ICD-11: 6A60] |
P08908 |
5HT1A_HUMAN |
Bulimia nervosa [ICD-11: 6B81] |
P08908 |
5HT1A_HUMAN |
Coronary atherosclerosis [ICD-11: BA80] |
P08908 |
5HT1A_HUMAN |
Dementia [ICD-11: 6D80-6D8Z] |
P08908 |
5HT1A_HUMAN |
Hypoactive sexual desire dysfunction [ICD-11: HA00] |
P08908 |
5HT1A_HUMAN |
Insomnia [ICD-11: 7A00-7A0Z] |
P08908 |
5HT1A_HUMAN |
Psychotic disorder [ICD-11: 6A20-6A25] |
P08908 |
5HT1A_HUMAN |
Social anxiety disorder [ICD-11: 6B04] |
P08908 |
5HT1A_HUMAN |
Ejaculatory dysfunction [ICD-11: HA03] |
P08908 |
5HT1A_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P08908 |
5HT1A_HUMAN |
Addictive disorder [ICD-11: 6C50-6C5Z] |
P08908 |
5HT1A_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P08908 |
5HT1A_HUMAN |
Episode [ICD-11: N.A.] |
P08908 |
5HT1A_HUMAN |
Dystonic disorder [ICD-11: 8A02] |
P08908 |
5HT1A_HUMAN |
Post-traumatic stress disorder [ICD-11: 6B40] |
P08908 |
5HT1A_HUMAN |
Binge eating disorder [ICD-11: 6B82] |
P08908 |
5HT1A_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P08908 |
5HT1A_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |